Viral load testing in a resource-limited setting: Quality control is critical

Journal of the International AIDS Society

Volumn 14, Issue 1, 2011, Pages

  Greig, Jane ^a   Du Cros, Philipp ^a   Klarkowski, Derryck ^a   Mills, Clair ^a   Jørgensen, Steffen ^b   Harrigan, P Richard ^c   O'Brien, Daniel P ^a  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b Hospital South   (Denmark)

^c BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA SOUTH OF THE SAHARA; ARTICLE; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; OUTCOME ASSESSMENT; PATIENT COUNSELING; PRIORITY JOURNAL; QUALITY CONTROL; RELIABILITY; TREATMENT DURATION; VIRUS INHIBITION; VIRUS LOAD; VIRUS LOAD TEST; DIAGNOSIS, MEASUREMENT AND ANALYSIS; HEALTH CARE PLANNING; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; METHODOLOGY; PHYSIOLOGY; STANDARD; VIROLOGY;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; CLINICAL LABORATORY TECHNIQUES; HEALTH RESOURCES; HIV INFECTIONS; HIV-1; HUMANS; QUALITY CONTROL; VIRAL LOAD;

EID: 79955811842     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-14-23     Document Type: Article

References (21)

1. Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings. R Kantor L Diero A Delong L Kamle S Muyonga F Mambo E Walumbe W Emonyi P Chan EJ Carter J Hogan N Buziba, Clin Infect Dis 2009 49 454 462 10.1086/600396 19569972
2. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria. JJ van Oosterhout L Brown R Weigel JJ Kumwenda D Mzinganjira N Saukila B Mhango T Hartung S Phiri MC Hosseinipour, Trop Med Int Health 2009 14 856 861 10.1111/j.1365-3156.2009.02309.x 19552661
3. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. DART Trial Team, Lancet 2010 375 123 131 20004464
4. Utility of Routine Viral Load, CD4 Cell Count, and Clinical Monitoring among HIV-Infected Adults in Uganda: A Randomized Trial [abstract]. A Coutinho J Mermin J Ekwaru W Were R Bunnell F Kaharuza L Alexander P Solberg J Tappero D Moore, 15th Conference on Retroviruses and Opportunistic Infections; February 2008; Boston, US http://www.retroconference.org/2008/Abstracts/30881.htm 19401606
5. Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring. The ART-LINC of IeDEA Study Group, AIDS 2009 23 1867 1874 19531928
6. HIV viral load monitoring in resource-limited regions: optional or necessary? A Calmy N Ford B Hirschel SJ Reynolds L Lynen E Goemaere F Garcia de la Vega L Perrin W Rodriguez, Clin Infect Dis 2007 44 128 134 10.1086/510073 17143828 (Pubitemid 44968997)
7. WHO, Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents Geneva: World Health Organization 2009
8. Laboratory medicine in Africa: a barrier to effective health care. CA Petti CR Polage TC Quinn AR Ronald MA Sande, Clin Infect Dis 2006 42 377 382 10.1086/499363 16392084 (Pubitemid 43122314)
9. HIV-1 viral load assays for resource-limited settings. SA Fiscus B Cheng SM Crowe L Demeter C Jennings V Miller R Respess W Stevens the Forum for Collaborative HIV Research Alternative Viral Load Assay Working Group, PLoS Medicine 2006 3 1743 1750 (Pubitemid 44721815)
10. Statistical methods for assessing agreement between two methods of clinical measurement. JM Bland DG Altman, Int J Nurs Stud 2010 47 931 936 10.1016/j.ijnurstu.2009.10.001
11. WHO, Antiretroviral therapy for adults and adolescents in resource-limited settings: towards universal access Geneva: World Health Organization 2006
12. Outcomes of a remote, decentralized health center-based HIV/AIDS antiretroviral program in Zambia, 2003 to 2007. R Elema C Mills O Yun K Lokuge C Ssonko N Nyirongo V Mtonga H Zulu D Tu M Verputten DP O'Brien, J Int Assoc Physicians AIDS Care (Chic Ill) 2009 8 60 67 10.1177/1545109709331472
13. Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia. L Ferradini D Laureillard N Prak C Ngeth M Fernandez L Pinoges G Puertas AM Taburet N Ly C Rouzioux S Balkan C Quillet J-F Delfraissy, AIDS 2007 21 2293 2301 10.1097/QAD.0b013e32828cc8b7 18090277 (Pubitemid 350287455)
14. Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. RE Barth MF Schim van der Loeff R Schuurman AIM Hoepelman AMJ Wensing, Lancet Infect Dis 2010 10 155 166 10.1016/S1473-3099(09)70328-7 20185094
15. Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1000 clinical specimens. R Galli L Merrick M Friesenhahn R Ziermann, J Clin Virol 2005 34 245 252 10.1016/j.jcv.2004.12.012 16286047 (Pubitemid 41605439)
16. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples. A Berger L Scherzed M Stürmer W Preiser HW Doerr HF Rabenau, J Clin Virol 2005 33 43 51 10.1016/j.jcv.2004.09.025 15797364 (Pubitemid 40431576)
17. Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5. T Elbeik WG Alvord R Trichavaroj M de Souza R Dewar A Brown D Chernoff NL Michael P Nassos K Hadley VL Ng, JAIDS 2002 29 330 339 11917236 (Pubitemid 34288885)
18. Are laboratory services coming of age in sub-Saharan Africa? I Bates K Maitland, Clin Infect Dis 2006 42 383 384 10.1086/499368 16392085 (Pubitemid 43122315)
19. WHO, HIV Drug Resistance Training. Module 11: Quality Control and Quality Assurance http://www.who.int/entity/hiv/pub/drugresistance/HIVDR-Mod-11-QAQC. ppt
20. Scaling up antiretroviral treatment in resource-poor settings [Correspondence]. HG Batz M Guillerm G Gonsalves, Lancet 2006 368 445 16890819
21. DART points the way for HIV treatment programmes. A Phillips J van Oosterhout, Lancet 2010 375 96 98 10.1016/S0140-6736(09)62103-6 20004465